1. Five plasma proteins can predict the development of metabolic dysfunction-associated steatotic liver disease up to 16 years before symptoms.
2. The predictive model showed improved accuracy rates when combined with clinical parameters.
3. MASLD has supplanted the term NAFLD.
4. The predictive capability was validated in a separate Chinese cohort.
5. Further investigations are underway to explore potential mechanistic pathways.

Source: DDW